Printer Friendly

Abbott to ship new glucose test strips.

ALAMEDA, Calif. -- Abbott Diabetes Care has received 510(k) clearance from the Food and Drug Administration for its FreeStyle blood glucose test strips.

The FreeStyle strips are said to minimize interference during blood glucose testing and are designed to offer a better testing experience. In a similar fashion to the recently cleared FreeStyle Lite blood glucose test strips, the new strips do not use the GDH-PQQ1 enzyme, which can be affected by common nonglucose sugars. Instead, they employ a GDH-FAD2 enzyme which is unaffected by common nonglucose sugars (such as maltose or galactose) and reduces the potential for other interference.

"Abbott's new FreeStyle test strips offer innovative technology that delivers on what patients and health care professionals demand in diabetes care," comments Heather Mason, senior vice president at Abbott Diabetes Care. "The technology minimizes interference and is designed to make the new FreeStyle test strips easier to use."

The new strips are compatible with all FreeStyle blood glucose monitoring systems, eliminating the need to switch meters. They feature a tapered design with tabs to offer a better blood glucose testing experience. The strips are also designed to ensure faster blood application and reduce the number of error messages and wasted test strips.

The first shipments of the new test strips will be sent to United States customers in August. Abbott says retailers can expect widespread availability by the end of October.

COPYRIGHT 2010 Racher Press, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2010 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:RX/News; Abbott Diabetes Care; FreeStyle
Comment:Abbott to ship new glucose test strips.(RX/News)(Abbott Diabetes Care)(FreeStyle)
Publication:Chain Drug Review
Article Type:Brief article
Geographic Code:1U9CA
Date:Jul 19, 2010
Words:231
Previous Article:Central fill promises to make pharmacies more efficient.
Next Article:Allscripts, Eclipsys to use technology to 'create collaboration'.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters